Both medium and high doses of PMG used in this study significantly increased SOD, CAT, and GSH-Px activities but decreased the MDA level (p value < 0.001, 0.05, 0.001, and 0.001, respectively; compared to the HCHF+MCAO+vehicle group) in MetS rats with MCAO. This evidence concerns the gene CAT and metabolic syndrome.